Patents Assigned to Targeted Growth, Inc.
  • Patent number: 10070601
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soy bean.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: September 11, 2018
    Assignee: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Publication number: 20170275640
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Application
    Filed: March 23, 2017
    Publication date: September 28, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Paul OLIVIER, Jay DEROCHER, James ROBERTS
  • Patent number: 9745596
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: August 29, 2017
    Assignees: Targeted Growth, Inc., The Regents of the University of California
    Inventors: Jean Paul Olivier, Tom Todaro, Jorge Dubcovsky, Wenjun Zhang
  • Publication number: 20170183680
    Abstract: The present invention provides expression vectors comprising polynucleotides encoding mutant Zea mays KRP dominant negative proteins, and methods of using the same. In addition, transgenic plants expressing said KRP dominant negative proteins are provided. Furthermore, methods of increasing average seed weight, seed size, seed number and/or yield of a plant by using said KRP dominant negative proteins are provided.
    Type: Application
    Filed: March 2, 2017
    Publication date: June 29, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, James Michael ROBERTS
  • Publication number: 20170142919
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soy bean.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 25, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul OLIVIER, Dayna L. LOEFFLER
  • Patent number: 9637754
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: May 2, 2017
    Assignee: Targeted Growth, Inc.
    Inventors: Paul Olivier, Jay Derocher, James Roberts
  • Patent number: 9556448
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soybean.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: January 31, 2017
    Assignee: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Patent number: 9062323
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: June 23, 2015
    Assignees: The Regents of the University of California, Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Tom Todaro, Jorge Dubcovsky, Wenjun Zhang
  • Publication number: 20140331362
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Application
    Filed: April 15, 2014
    Publication date: November 6, 2014
    Applicant: TARGETED GROWTH, INC.
    Inventors: Paul OLIVIER, Jay DEROCHER, James Roberts
  • Publication number: 20140215653
    Abstract: The invention provides early embryo and early endosperm specific or preferred promoters, which are capable of driving and/or regulating the expression of an operably linked nucleic acid in a maize plant during early development of embryo and/or endosperm, and methods of isolating them. The promoters are derived from Zea mays or other plant species. The invention also provides compositions comprising one or more said promoters and methods of using the same.
    Type: Application
    Filed: October 23, 2013
    Publication date: July 31, 2014
    Applicant: TARGETED GROWTH, INC.
    Inventors: Jean Paul OLIVIER, James Michael Roberts, Fred Cross, Carolyn Hutcheon, Asha Palta
  • Publication number: 20140201866
    Abstract: The present invention provides methods and compositions for increasing the seed size and/or seed number in plants. In particular, the methods and compositions provide for the over expression of a plant growth and/or development related or associated gene during embryo development. Transgenic plants transformed with genetic constructs having the plant growth and/or development associated gene under the control of an early phase-specific embryo promoter provides mature plants in the field that produce larger and/or more seeds. Methods for selection growth and development associated genes that provide transgenic plants with a higher yield phenotype are also provided.
    Type: Application
    Filed: January 7, 2014
    Publication date: July 17, 2014
    Applicant: TARGETED GROWTH, INC.
    Inventors: JAY DEROCHER, THU NGUYEN
  • Patent number: 8742205
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: June 3, 2014
    Assignee: Targeted Growth, Inc.
    Inventors: Paul Olivier, Jay DeRocher, James M. Roberts
  • Publication number: 20140143900
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soybean.
    Type: Application
    Filed: April 11, 2012
    Publication date: May 22, 2014
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Publication number: 20140068817
    Abstract: The present invention provides expression vectors comprising polynucleotides encoding chimeric sucrose isomerases, and methods of using the same. In addition, transgenic plants expressing said chimeric sucrose isomerases are provided. Furthermore, methods of increasing average seed weight, seed number and/or seed size of a plant by using said chimeric sucrose isomerases are provided.
    Type: Application
    Filed: March 5, 2012
    Publication date: March 6, 2014
    Applicant: Targeted Growth, Inc.
    Inventors: Stefan Dittmar, George Singletary, Asha Palta, Barry Stoddard, Paul Olivier
  • Patent number: 8653325
    Abstract: The present invention provides methods and compositions for increasing the seed size and/or seed number in plants. In particular, the methods and compositions provide for the over expression of a plant growth and/or development related or associated gene during embryo development. Transgenic plants transformed with genetic constructs having the plant growth and/or development associated gene under the control of an early phase-specific embryo promoter provides mature plants in the field that produce larger and/or more seeds. Methods for selection growth and development associated genes that provide transgenic plants with a higher yield phenotype are also provided.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: February 18, 2014
    Assignee: Targeted Growth, Inc.
    Inventors: Jay DeRocher, Thu Nguyen
  • Publication number: 20130344549
    Abstract: This disclosure describes genetically modified photosynthetic microorganisms, e.g., Cyanobacteria, that overexpress an acyl carrier protein (ACP), an acyl-ACP synthase (Aas), or both, optionally in combination with one or more overexpressed or exogenous lipid biosynthesis proteins, and/or one or more overexpressed or exogenous glycogen breakdown proteins. Exemplary biosynthesis proteins include diacyglycerol acyltransferases, thioesterases, phosphatidate phosphatases, phospholipases, triacylglycerol (TAG) hydrolases, fatty acyl-CoA synthetases, and/or acetyl-CoA carboxylases, including combinations thereof. Also included are photosynthetic microorganisms comprising mutations or deletions in a glycogen biosynthesis or storage pathway, which accumulate a reduced amount of glycogen under reduced nitrogen conditions as compared to a wild type photosynthetic microorganism.
    Type: Application
    Filed: December 19, 2011
    Publication date: December 26, 2013
    Applicant: Targeted Growth, Inc.
    Inventors: James Roberts, Fred Cross, Margaret Mary McCormick, Ernesto Javier Munoz, Brett K. Kaiser, Michael Carleton
  • Patent number: 8324458
    Abstract: The invention relates to a Camelina sativa (L.) Crantz spring-type seed designated as ‘SO-60’ derived from a cross between camelina accessions with high yield and oil quality attributes following conventional breeding methodologies.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: December 4, 2012
    Assignee: Targeted Growth, Inc.
    Inventor: Fernando Guillen-Portal
  • Patent number: 8319021
    Abstract: The invention relates to a Camelina sativa (L.) Crantz spring-type seed designated as ‘SO-50’ derived from a cross between camelina accessions with high yield and oil quality attributes following conventional breeding methodologies.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: November 27, 2012
    Assignee: Targeted Growth, Inc.
    Inventor: Fernando Guillen-Portal
  • Patent number: 8319020
    Abstract: The invention relates to a Camelina sativa (L.) Crantz spring-type seed designated as ‘SO-40’ derived from a cross between camelina accessions with high yield and oil quality attributes following conventional breeding methodologies.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: November 27, 2012
    Assignee: Targeted Growth, Inc.
    Inventor: Fernando Guillen-Portal
  • Publication number: 20120284813
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Application
    Filed: April 11, 2012
    Publication date: November 8, 2012
    Applicant: TARGETED GROWTH, INC.
    Inventors: Jean Paul OLIVIER, Tom TODARO, Jorge DUBCOVSKY